Laidlaw, K. M., Berhan, S., Liu, S., Silvestri, G., Holyoake, T. L., Frank, D. A., . . . Arbiser, J. L. (2016). Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. Oncotarget.
Chicago Style CitationLaidlaw, Kamilla M.E., et al. "Cooperation of Imipramine Blue and Tyrosine Kinase Blockade Demonstrates Activity against Chronic Myeloid Leukemia." Oncotarget 2016.
Cita MLALaidlaw, Kamilla M.E., et al. "Cooperation of Imipramine Blue and Tyrosine Kinase Blockade Demonstrates Activity against Chronic Myeloid Leukemia." Oncotarget 2016.
Atenció: Aquestes cites poden no estar 100% correctes.